| Typ : |
tidningen |
| internet länkar : |
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4526 |
|
| forskargrupper : |
Rochester - Wegmans School of Pharmacy |
| Författare : |
Zhao F, Dave V.S, Mar M, Perri J. |
| Titel : |
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. |
| Hänvisningar : |
Int J Pharm Compound 22,5:433-439 2018 |
|
| Evidensgrad : |
|
| fysikalisk stabilitet : |
|
| kemisk stabilitet : |
|
| andra metoder : |
|
| Kommentarer : |
|
Förteckning över substanser
 Eslicarbazepine acetate
|
 |
 |
 |
 |
1200 mg
Aptiom® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
 |
| 63 |
 |
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
2-8°C |
|
| 63 |
|
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
25°C |
|
| 63 |
|
|
|
|
|
|
1200 mg
Aptiom® |
| OraPlus® / OraSweet SF® (1:1) |
>> 30 mL |
|
25°C |
|
| 63 |
|
|
|
|
|
